067370 — Sun Bio Income Statement
0.000.00%
Last trade - 00:00- KR₩95bn
- KR₩120bn
- KR₩9bn
Annual income statement for Sun Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,459 | 9,965 | 7,420 | 12,292 | 8,683 |
| Cost of Revenue | |||||
| Gross Profit | 3,439 | 6,728 | 4,514 | 8,636 | 5,921 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 3,820 | 6,588 | 7,229 | 7,100 | 9,216 |
| Operating Profit | 1,639 | 3,377 | 191 | 5,192 | -533 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,202 | 1,133 | 937 | 5,550 | -227 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,202 | 285 | 869 | 4,607 | -104 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,202 | 285 | 869 | 4,607 | -104 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 1,168 | 285 | 869 | 4,607 | -104 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 100 | 24.5 | 72.6 | 374 | -8.48 |
| Dividends per Share |